Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +1.35% | 0.00% | -22.28% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 25.18M 2.02B |
---|---|---|---|---|---|
Net income 2024 * | -41M -3.28B | Net income 2025 * | -36M -2.88B | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.44M 676M | Net Debt 2025 * | 17.76M 1.42B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.62
x | P/E ratio 2025 * |
-0.75
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.75% |
Latest transcript on Unity Biotechnology, Inc.
1 day | +1.35% | ||
Current month | -8.54% | ||
1 month | -7.98% | ||
3 months | -11.76% | ||
6 months | -17.58% | ||
Current year | -22.28% |
Managers | Title | Age | Since |
---|---|---|---|
Anirvan Ghosh
CEO | Chief Executive Officer | 60 | 29/03/20 |
Founder | 56 | 29/03/09 | |
Lynne Sullivan
DFI | Director of Finance/CFO | 58 | 31/07/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Berns
BRD | Director/Board Member | 57 | 26/03/18 |
Director/Board Member | 52 | 28/02/15 | |
Keith Leonard
CHM | Chairman | 62 | 31/12/15 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.5 | +1.35% | 38,503 |
25/04/24 | 1.48 | +0.68% | 17,141 |
24/04/24 | 1.47 | -1.34% | 82,056 |
23/04/24 | 1.49 | +0.68% | 36,550 |
22/04/24 | 1.48 | -1.33% | 71,949 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.28% | 25.18M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- UBX Stock